Skip to main content
. 2023 Dec 1;5(12):e1012. doi: 10.1097/CCE.0000000000001012

TABLE 1.

Characteristics of the Study Population During ICU Days 1–7 Based on Delirium Occurrence After Multiple Imputation by Chained Equations Use

Total (n = 4,064) Delirium Ever (n = 1,250) Delirium Never (n = 2,814)
Baseline characteristics
 Age, median (IQR), yr 64 (53–72) 65 (55–74) 63 (51–71)
 Sex, male, n (%) 2,582 (63.5) 832 (66.6) 1,750 (62.2)
 Charlson Comorbidity Scale Score, median (IQR) 1 (0–2) 1 (0–2) 1 (0–2)
 Body mass index, median (IQR) 25.7 (22.9–29.1) 25.5 (22.9–28.7) 25.7 (22.8–29.3)
 Admission type, n (%)
  Medical 1,531 (37.7) 581 (46.5) 950 (33.8)
  Elective surgery 1,744 (42.9) 360 (28.8) 1,384 (49.2)
  Acute surgery 789 (19.4) 309 (24.7) 480 (17.1)
 Acute Physiology and Chronic Health Evaluation IV score, median (IQR) 55 (40–76) 68 (52–85) 50 (36–69)
Daily ICU characteristics
 Days of no pain, median (IQR) 1 (1–3) 2 (1–3) 1 (1–2)
 Presence of any pain, n (%) 2,444 (60.1) 744 (59.5) 1,699 (60.4)
 Days of mild pain, median (IQR) 1.0 (1.0–2.0) 2.0 (1.0–3.0) 1.0 (1.0–2.0)
 Days of moderate pain, median (IQR) 1.0 (1.0–2.0) 1.0 (1.0–2.0) 1.0 (1.0–2.0)
 Days of severe pain, median (IQR) 1.0 (1.0–1.0) 1 (1–1.6) 1.0 (1.0–1.0)
 Maximum modified Sequential Organ Failure Assessment score, median (IQR) 6 (4-9) 8 (7–11) 6 (4–8)
 Use of invasive mechanical ventilation, n (%) 3,734 (91.2) 1,199 (95.9) 2,535 (90.1)
 Days of invasive mechanical ventilation, median (IQR) 2 (1–5) 5 (2–7) 2 (1–3)
 Benzodiazepine use, n (%) 1982 (48.8) 833 (66.6) 1149 (40.8)
 Days of benzodiazepine use, median (IQR) 2(1–3) 2 (1–4) 1 (1–2)
 Opioid use, n (%) 3,384 (83.3) 1,092 (87.4) 2,292 (81.4)
 Days of opioid use, median (IQR) 2 (1–4) 4 (2–6) 1 (1–3)

IQR = interquartile range.